Skip to main content

Table 1 Baseline patient characteristics

From: Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI

  Median IQR
Age, year 64 59–69
BMI, kg/m2 24.5 22.4–26.1
Comorbidity N %
 Hypertension 92 43.2
 DM 27 12.7
PSA level, ng/ml 5.35 4.0–7.5
Prostate volume, ml 31.2 23.2–41.2
Follow up period after RP, months 51 32–70
Tumor volume at specimen, cc 0.6 0.2–1.4
Biopsy Gleason score N %
 6 162 76.1
 7 37 17.4
  ≥ 8 14 6.6
Pathologic Gleason score N %
 6 115 54
 7 78 36.6
  ≥ 8 20 9.4
Pathologic T stage N %
  ≤ T2 185 86.9
  ≥ T3 28 13.1
ECE N %
  28 13.1
SVI N %
  1 0.5
PSM(R1) N %
  18 8.5
LVI N %
  3 1.4
PNI N %
  63 29.6
BCR N %
  29 13.6
  1. IQR Interquartile range, BMI Body mass index, DM Diabetes mellitus, PSA Prostate-specific antigen, RP Radical prostatectomy, ECE Extracapsular extension, SVI Seminal vesicle invasion, PSM Positive surgical margins, LVI Lymphovascular invasion, PNI Perineural invasion, BCR Biochemical recurrence